Isosorbide dinitrate sublingual therapy for inferior myocardial infarction: randomized trial to assess infarct size limitation. 1985

P Pabón Osuna, and L M García Moreno, and A Arribas Jimenez, and A Sala Sánchez-Castillo, and C Martín Luengo, and J Sánchez Hernández, and L Castaño Bazo, and M Cascón Bueno, and M Diego Dominguez, and C Ledesma García

To assess the potential of isosorbide dinitrate sublingual therapy for limiting myocardial infarct size, 41 patients with inferior acute myocardial infarction (AMI) were studied. Twenty patients were randomly assigned to the control group and 21 to the treatment group. Patients in the treatment group received 10 mg of isosorbide dinitrate every 2 hours for 72 hours. To estimate infarct size, QRS scoring, peak creatine kinase (CK) serum levels and CK curves were used. There were no significant differences between the 2 groups in maximal or cumulative activity of CK or QRS score (percent of left ventricle infarcted: 16% in the control group, 17% in the treatment group). In both groups the QRS score increased significantly by 13 hours after AMI, and the increase was highly significant by 19 to 23 hours. Thus, sublingual isosorbide dinitrate at the dosage given did not reduce infarct size in patients with inferior AMI.

UI MeSH Term Description Entries
D007548 Isosorbide Dinitrate A vasodilator used in the treatment of ANGINA PECTORIS. Its actions are similar to NITROGLYCERIN but with a slower onset of action. Cardonit 40,Dilatrate,Iso-Bid,Isodinit,Isoket,Isoket Retard-120,Isomak R,Isordil,Isotrate,Nitrosorbide,Sorbitrate,Sorbonit,Dinitrate, Isosorbide,Iso Bid,IsoBid,Isoket Retard 120,Isoket Retard120
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

P Pabón Osuna, and L M García Moreno, and A Arribas Jimenez, and A Sala Sánchez-Castillo, and C Martín Luengo, and J Sánchez Hernández, and L Castaño Bazo, and M Cascón Bueno, and M Diego Dominguez, and C Ledesma García
April 1982, Circulation,
P Pabón Osuna, and L M García Moreno, and A Arribas Jimenez, and A Sala Sánchez-Castillo, and C Martín Luengo, and J Sánchez Hernández, and L Castaño Bazo, and M Cascón Bueno, and M Diego Dominguez, and C Ledesma García
March 1990, International journal of cardiology,
P Pabón Osuna, and L M García Moreno, and A Arribas Jimenez, and A Sala Sánchez-Castillo, and C Martín Luengo, and J Sánchez Hernández, and L Castaño Bazo, and M Cascón Bueno, and M Diego Dominguez, and C Ledesma García
October 1977, British heart journal,
P Pabón Osuna, and L M García Moreno, and A Arribas Jimenez, and A Sala Sánchez-Castillo, and C Martín Luengo, and J Sánchez Hernández, and L Castaño Bazo, and M Cascón Bueno, and M Diego Dominguez, and C Ledesma García
January 1980, Revista espanola de cardiologia,
P Pabón Osuna, and L M García Moreno, and A Arribas Jimenez, and A Sala Sánchez-Castillo, and C Martín Luengo, and J Sánchez Hernández, and L Castaño Bazo, and M Cascón Bueno, and M Diego Dominguez, and C Ledesma García
November 1992, American heart journal,
P Pabón Osuna, and L M García Moreno, and A Arribas Jimenez, and A Sala Sánchez-Castillo, and C Martín Luengo, and J Sánchez Hernández, and L Castaño Bazo, and M Cascón Bueno, and M Diego Dominguez, and C Ledesma García
January 1977, Advances in internal medicine,
P Pabón Osuna, and L M García Moreno, and A Arribas Jimenez, and A Sala Sánchez-Castillo, and C Martín Luengo, and J Sánchez Hernández, and L Castaño Bazo, and M Cascón Bueno, and M Diego Dominguez, and C Ledesma García
May 1970, Circulation,
P Pabón Osuna, and L M García Moreno, and A Arribas Jimenez, and A Sala Sánchez-Castillo, and C Martín Luengo, and J Sánchez Hernández, and L Castaño Bazo, and M Cascón Bueno, and M Diego Dominguez, and C Ledesma García
November 1980, Journal of the National Medical Association,
P Pabón Osuna, and L M García Moreno, and A Arribas Jimenez, and A Sala Sánchez-Castillo, and C Martín Luengo, and J Sánchez Hernández, and L Castaño Bazo, and M Cascón Bueno, and M Diego Dominguez, and C Ledesma García
August 1988, Journal of the Indian Medical Association,
P Pabón Osuna, and L M García Moreno, and A Arribas Jimenez, and A Sala Sánchez-Castillo, and C Martín Luengo, and J Sánchez Hernández, and L Castaño Bazo, and M Cascón Bueno, and M Diego Dominguez, and C Ledesma García
March 1991, Southern medical journal,
Copied contents to your clipboard!